2014
DOI: 10.1097/shk.0000000000000169
|View full text |Cite
|
Sign up to set email alerts
|

Itraconazole, a Commonly Used Antifungal, Inhibits Fcγ Receptor–Mediated Phagocytosis

Abstract: Itraconazole (ICZ)‡ is commonly used for the treatment of fungal infections, particularly in immunocompromised patients. In addition, ICZ has been recently found to have anti-angiogenic effects and is currently being tested as a new chemotherapeutic agent in several cancer clinical trials. We have previously shown that ICZ impaired complex N-linked glycosylation processing, leading to the accumulation of high-mannose glycoproteins on the surface of macrophages. This investigation was directed at determining th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
7
1

Year Published

2015
2015
2021
2021

Publication Types

Select...
7

Relationship

3
4

Authors

Journals

citations
Cited by 11 publications
(8 citation statements)
references
References 35 publications
0
7
1
Order By: Relevance
“…Additionally, others have shown that ITA affects the glycosylation and trafficking of other cell surface molecules including CD14 and Fc receptors; however, the relevant cellular target responsible for ITA's effects on receptor trafficking remains unknown (36,37). Recently, others have reported that ITA inhibits enterovirus replication by binding to oxysterol binding protein (OSBP) and that ITA modulates mTORC1 activity by inhibiting the mitochondrial protein voltagedependent anion channel 1 (VDAC1) (38,39).…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, others have shown that ITA affects the glycosylation and trafficking of other cell surface molecules including CD14 and Fc receptors; however, the relevant cellular target responsible for ITA's effects on receptor trafficking remains unknown (36,37). Recently, others have reported that ITA inhibits enterovirus replication by binding to oxysterol binding protein (OSBP) and that ITA modulates mTORC1 activity by inhibiting the mitochondrial protein voltagedependent anion channel 1 (VDAC1) (38,39).…”
Section: Discussionmentioning
confidence: 99%
“…Cells were then washed and at least 100,000 live cells per sample were analyzed using a BD Accuri C6 Flow Cytometer (BD Biosciences). Flow cytometry data analysis was performed using FlowJo software (FlowJo) as previously described (18). …”
Section: Methodsmentioning
confidence: 99%
“…Our recent observations also indicated that FcγR expression levels were altered by inhibition of cholesterol biosynthesis. 38 The promoter region of this gene did not display any lipid-driving element that could predict a regulation at the transcriptional level, although we cannot discount the involvement of transcription enhancers. Additionally, changes in mRNA stability may be involved in regulating changes in FcγR expression levels after exposure to different cholesterol contents.…”
Section: Discussionmentioning
confidence: 73%
“…36,37 Moreover, we have recently found that incubation of Mϕs with itraconazole, another inhibitor of cholesterol synthesis, affected phagocytosis. 38 The differences in phagocytic function between suspension and attached Mϕs were proportional to the levels of Fc receptors in these cells. The mechanism for the modulation of FcγR expression by cholesterol is unknown.…”
Section: Discussionmentioning
confidence: 96%